Moreover, further explorations could also focus on investigating the molecular mechanism of L-FABP in COVID-19 progression along with the effects of malabsorption and/or abnormal lipid metabolism, which may be potential therapeutic targets of COVID-19. This evidence concerns the gene FABP1 and COVID-19.